Timothy Babinchak - Concepedia

Author

Timothy Babinchak

Institut Français du Textile et de l'Habillement

Also Known As

David Gardiner, Ron Pedersen, T. Babinchak, T. J. Babinchak, Timothy Babinchak, Timothy J. Babinchak, Timothy J. Babinchak

Publications

Citations

H-Index

Concepts

All Affiliations

Institut Français du Textile et de l'Habillement Thomas Jefferson University Cognizant (United States)University at Buffalo, State University of New York Pfizer (United States)

About

Timothy Babinchak is an author at Institut Français du Textile et de l'Habillement specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Health Sciences	6	6	558
3	Critical Care Medicine	1	1	11
4	Emergency Medicine	1	1	19
5	Epidemiology	1	1	103

Timothy Babinchak

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
A Randomized and Blinded Multicenter Trial of High‐Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects John Rex, Peter G. Pappas, Adolf W. Karchmer, Clinical Infectious Diseases	2003	493
The Efficacy and Safety of Tigecycline in the Treatment of Skin and Skin‐Structure Infections: Results of 2 Double‐Blind Phase 3 Comparison Studies with Vancomycin‐Aztreonam Evelyn J. Ellis‐Grosse, Timothy Babinchak, Nathalie Dartois, Clinical Infectious Diseases Skin‐structure InfectionsAntibioticsComparison StudiesVancomycin-aztreonam CombinationTopical Drug	2005	414
The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial Data Timothy Babinchak, Evelyn J. Ellis‐Grosse, Nathalie Dartois, Clinical Infectious Diseases Complicated Intra‐abdominal InfectionsHealth SciencesAntimicrobial StewardshipAntibioticsClinical Trials	2005	381
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744] María Eugenia Oliva, Arcot Rekha, Albert E. Yellin, BMC Infectious Diseases	2005	153
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study I Florescu, Mircea Beuran, R Dimov, Journal of Antimicrobial Chemotherapy	2008	135
Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy Joseph Kulkosky, Giuseppe Nunnari, Miguel Otero, The Journal of Infectious Diseases Translational MedicineStimulation TherapyPlasma Viral RnaTreatment And PreventionNeurovirology	2002	127
Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections Alison Meagher, Julie Passarell, Brenda Cirincione, Antimicrobial Agents and Chemotherapy Predominant PathogensHealth SciencesSkin TestingTigecycline EfficacyHealthcare-associated Infection	2007	111
Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections Julie Passarell, Alison Meagher, Kathryn Liolios, Antimicrobial Agents and Chemotherapy Predominant PathogensAntimicrobial StewardshipE. Coli PathogensTigecycline EfficacyHealthcare-associated Infection	2007	103
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae Krasimir Vasilev, Galina Reshedko, Remus Orăsan, Journal of Antimicrobial Chemotherapy	2008	101
Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials David Gardiner, Gary Dukart, Angel Cooper, Clinical Infectious Diseases	2009	93

Page 1